Related Experiment Videos
Positive I-123-MIBG-scintigraphy in osteosarcoma
K von der Hardt1, H J Bair, T Kirchner
1Department of Pediatrics, University of Erlangen-Nürnberg, Germany.
Nuklearmedizin. Nuclear Medicine
|April 21, 1998
Summary
I-123-MIBG scintigraphy is standard for neuroendocrine tumors. This case shows positive uptake in pediatric osteosarcoma, highlighting that unusual results can occur with this imaging method.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiopharmaceuticals
Background:
- I-123-MIBG scintigraphy is a well-established diagnostic tool.
- It is primarily used for detecting neuroendocrine and neurocrest-derived tumors such as neuroblastoma and pheochromocytoma.
Observation:
- A pediatric patient diagnosed with osteosarcoma was evaluated.
- The patient underwent I-123-MIBG scintigraphy as part of their diagnostic workup.
Findings:
- The I-123-MIBG scan revealed positive uptake in the osteosarcoma.
- This finding is atypical as osteosarcoma is not typically considered a neuroendocrine or neurocrest-derived tumor.
Implications:
- This case demonstrates that I-123-MIBG scintigraphy can yield unexpected positive results in non-traditional tumor types.
- Clinicians should consider the possibility of unusual uptake patterns even with established imaging protocols.
- Further investigation may be warranted to understand the biological basis for MIBG uptake in osteosarcoma.